Free Trial

electroCore (ECOR) Competitors

electroCore logo
$4.92 -0.39 (-7.34%)
Closing price 04:00 PM Eastern
Extended Trading
$5.24 +0.32 (+6.40%)
As of 06:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ECOR vs. PDEX, ZJYL, PROF, CVRX, LUCD, INFU, ICAD, OBIO, MGRM, and MBOT

Should you be buying electroCore stock or one of its competitors? The main competitors of electroCore include Pro-Dex (PDEX), Jin Medical International (ZJYL), Profound Medical (PROF), CVRx (CVRX), Lucid Diagnostics (LUCD), InfuSystem (INFU), iCAD (ICAD), Orchestra BioMed (OBIO), Monogram Orthopaedics (MGRM), and Microbot Medical (MBOT). These companies are all part of the "medical equipment" industry.

electroCore vs.

Pro-Dex (NASDAQ:PDEX) and electroCore (NASDAQ:ECOR) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their community ranking, analyst recommendations, valuation, media sentiment, profitability, institutional ownership, risk, dividends and earnings.

15.3% of Pro-Dex shares are owned by institutional investors. Comparatively, 26.7% of electroCore shares are owned by institutional investors. 47.5% of Pro-Dex shares are owned by company insiders. Comparatively, 19.7% of electroCore shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Pro-Dex has a net margin of 11.06% compared to electroCore's net margin of -54.40%. Pro-Dex's return on equity of 21.68% beat electroCore's return on equity.

Company Net Margins Return on Equity Return on Assets
Pro-Dex11.06% 21.68% 12.40%
electroCore -54.40%-154.45%-69.16%

Pro-Dex presently has a consensus target price of $52.00, indicating a potential upside of 17.12%. electroCore has a consensus target price of $25.50, indicating a potential upside of 418.29%. Given electroCore's higher probable upside, analysts plainly believe electroCore is more favorable than Pro-Dex.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pro-Dex
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
electroCore
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Pro-Dex has a beta of 0.37, meaning that its stock price is 63% less volatile than the S&P 500. Comparatively, electroCore has a beta of 0.92, meaning that its stock price is 8% less volatile than the S&P 500.

electroCore received 11 more outperform votes than Pro-Dex when rated by MarketBeat users. Likewise, 62.55% of users gave electroCore an outperform vote while only 61.90% of users gave Pro-Dex an outperform vote.

CompanyUnderperformOutperform
Pro-DexOutperform Votes
156
61.90%
Underperform Votes
96
38.10%
electroCoreOutperform Votes
167
62.55%
Underperform Votes
100
37.45%

Pro-Dex has higher revenue and earnings than electroCore. electroCore is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pro-Dex$64.12M2.26$2.13M$2.8015.86
electroCore$26.46M1.38-$18.83M-$1.56-3.15

In the previous week, Pro-Dex had 2 more articles in the media than electroCore. MarketBeat recorded 2 mentions for Pro-Dex and 0 mentions for electroCore. electroCore's average media sentiment score of 1.92 beat Pro-Dex's score of 1.26 indicating that electroCore is being referred to more favorably in the news media.

Company Overall Sentiment
Pro-Dex Positive
electroCore Very Positive

Summary

Pro-Dex beats electroCore on 10 of the 17 factors compared between the two stocks.

Get electroCore News Delivered to You Automatically

Sign up to receive the latest news and ratings for ECOR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ECOR vs. The Competition

MetricelectroCoreElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$36.51M$3.26B$5.35B$8.38B
Dividend YieldN/A1.73%5.22%4.10%
P/E Ratio-2.6916.6026.8419.71
Price / Sales1.3885.43391.39116.98
Price / CashN/A44.0938.2534.62
Price / Book3.973.736.794.50
Net Income-$18.83M$94.03M$3.23B$248.18M
7 Day Performance6.72%2.20%4.07%1.14%
1 Month Performance-24.42%25.87%12.52%15.20%
1 Year Performance-27.65%-13.57%16.83%6.56%

electroCore Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ECOR
electroCore
2.9359 of 5 stars
$4.92
-7.3%
$25.50
+418.3%
-24.0%$36.51M$26.46M-2.6950Positive News
PDEX
Pro-Dex
2.6471 of 5 stars
$40.27
-9.1%
$52.00
+29.1%
+130.9%$131.32M$64.12M20.03140News Coverage
Positive News
Gap Up
High Trading Volume
ZJYL
Jin Medical International
N/A$0.90
+8.2%
N/A-74.2%$129.93M$23.50M0.00245
PROF
Profound Medical
2.5443 of 5 stars
$4.28
-7.6%
$11.50
+168.7%
-39.2%$128.63M$10.68M-3.19150High Trading Volume
CVRX
CVRx
2.9248 of 5 stars
$4.75
-0.4%
$14.50
+205.3%
-15.6%$123.77M$51.29M-1.77160Gap Up
High Trading Volume
LUCD
Lucid Diagnostics
3.0297 of 5 stars
$1.10
-2.7%
$3.50
+218.2%
+39.8%$115.92M$4.35M-0.9670Gap Up
INFU
InfuSystem
2.4561 of 5 stars
$5.48
+2.0%
$13.00
+137.2%
N/A$115.17M$134.86M91.35410News Coverage
High Trading Volume
ICAD
iCAD
0.4759 of 5 stars
$3.71
+3.1%
N/A+141.5%$101.83M$19.61M-28.54140News Coverage
Analyst Forecast
Gap Up
High Trading Volume
OBIO
Orchestra BioMed
2.831 of 5 stars
$2.65
flat
$14.20
+435.8%
-43.6%$101.53M$2.64M-1.654Gap Up
MGRM
Monogram Orthopaedics
3.2412 of 5 stars
$2.63
-1.5%
$5.40
+105.3%
+40.1%$92.81M$364,999.00-5.6028Earnings Report
Gap Up
MBOT
Microbot Medical
1.8406 of 5 stars
$2.55
+1.2%
$9.00
+252.9%
+162.1%$88.60MN/A-3.1920Positive News
Earnings Report
Gap Up

Related Companies and Tools


This page (NASDAQ:ECOR) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners